Follow
Bimmer Claessen
Bimmer Claessen
Amsterdam University Medical Centres
Verified email at amsterdamumc.nl
Title
Cited by
Cited by
Year
In-stent restenosis in the drug-eluting stent era
GD Dangas, BE Claessen, A Caixeta, EA Sanidas, GS Mintz, R Mehran
Journal of the American College of Cardiology 56 (23), 1897-1907, 2010
8492010
Impact of bleeding on mortality after percutaneous coronary intervention: results from a patient-level pooled analysis of the REPLACE-2 (Randomized Evaluation of PCI Linking†…
R Mehran, S Pocock, E Nikolsky, GD Dangas, T Clayton, BE Claessen, ...
JACC: Cardiovascular Interventions 4 (6), 654-664, 2011
4102011
Percutaneous intervention for concurrent chronic total occlusions in patients with STEMI: the EXPLORE trial
JPS Henriques, LP Hoebers, T RŚmunddal, P Laanmets, E Eriksen, ...
Journal of the American College of Cardiology 68 (15), 1622-1632, 2016
3372016
Long-term outcome of percutaneous coronary intervention for chronic total occlusions
R Mehran, BE Claessen, C Godino, GD Dangas, K Obunai, S Kanwal, ...
JACC: Cardiovascular Interventions 4 (9), 952-961, 2011
3202011
Prognostic impact of staged versus “one-time” multivessel percutaneous intervention in acute myocardial infarction: analysis from the HORIZONS-AMI (harmonizing outcomes with†…
R Kornowski, R Mehran, G Dangas, E Nikolsky, A Assali, BE Claessen, ...
Journal of the American College of Cardiology 58 (7), 704-711, 2011
3062011
Evaluation of the effect of a concurrent chronic total occlusion on long-term mortality and left ventricular function in patients after primary percutaneous coronary intervention
BEPM Claessen, RJ van der Schaaf, NJ Verouden, NK Stegenga, ...
JACC: Cardiovascular Interventions 2 (11), 1128-1134, 2009
2702009
Safety and efficacy outcomes of first and second generation durable polymer drug eluting stents and biodegradable polymer biolimus eluting stents in clinical practice†…
EP Navarese, K Tandjung, B Claessen, F Andreotti, M Kowalewski, ...
Bmj 347, 2013
2452013
Prognostic impact of a chronic total occlusion in a non-infarct-related artery in patients with ST-segment elevation myocardial infarction: 3-year results from the HORIZONS-AMI†…
BE Claessen, GD Dangas, G Weisz, B Witzenbichler, G Guagliumi, ...
European heart journal 33 (6), 768-775, 2012
2442012
ST-segment elevation myocardial infarction
B Vogel, BE Claessen, SV Arnold, D Chan, DJ Cohen, E Giannitsis, ...
Nature reviews Disease primers 5 (1), 39, 2019
1932019
Stent thrombosis: a clinical perspective
BE Claessen, JPS Henriques, FA Jaffer, R Mehran, JJ Piek, GD Dangas
JACC: Cardiovascular interventions 7 (10), 1081-1092, 2014
1882014
Meta-analysis on the impact of percutaneous coronary intervention of chronic total occlusions on left ventricular function and clinical outcome
LP Hoebers, BE Claessen, J Elias, GD Dangas, R Mehran, ...
International journal of cardiology 187, 90-96, 2015
1722015
Impact of in-hospital major bleeding on late clinical outcomes after primary percutaneous coronary intervention in acute myocardial infarction: the HORIZONS-AMI (Harmonizing†…
JW Suh, R Mehran, BE Claessen, K Xu, U Baber, G Dangas, H Parise, ...
Journal of the American College of Cardiology 58 (17), 1750-1756, 2011
1492011
Long-term impact of chronic kidney disease in patients with ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention: the HORIZONS-AMI†…
AJ Saltzman, GW Stone, BE Claessen, A Narula, S Leon-Reyes, G Weisz, ...
JACC: Cardiovascular Interventions 4 (9), 1011-1019, 2011
1402011
Two-year clinical, angiographic, and intravascular ultrasound follow-up of the XIENCE V everolimus-eluting stent in the treatment of patients with de novo native coronary†…
BE Claessen, MA Beijk, V Legrand, W Ruzyllo, A Manari, O Varenne, ...
Circulation: Cardiovascular Interventions 2 (4), 339-347, 2009
1392009
Efficacy and safety of alirocumab and evolocumab: a systematic review and meta-analysis of randomized controlled trials
P Guedeney, G Giustino, S Sorrentino, BE Claessen, A Camaj, ...
European heart journal 43 (7), e17-e25, 2022
1362022
Impact of hemodynamic support with Impella 2.5 versus intra-aortic balloon pump on prognostically important clinical outcomes in patients undergoing high-risk percutaneous†…
GD Dangas, AS Kini, SK Sharma, JPS Henriques, BE Claessen, ...
The American Journal of Cardiology 113 (2), 222-228, 2014
1352014
Effect of multivessel coronary disease with or without concurrent chronic total occlusion on one-year mortality in patients treated with primary percutaneous coronary†…
RJ van der Schaaf, BE Claessen, MM Vis, LP Hoebers, KT Koch, ...
The American journal of cardiology 105 (7), 955-959, 2010
1342010
Impact of lesion length and vessel size on clinical outcomes after percutaneous coronary intervention with everolimus-versus paclitaxel-eluting stents: pooled analysis from the†…
BE Claessen, PC Smits, DJ Kereiakes, H Parise, M Fahy, E Kedhi, ...
JACC: Cardiovascular Interventions 4 (11), 1209-1215, 2011
1242011
Paclitaxel-coated balloon angioplasty vs. drug-eluting stenting for the treatment of coronary in-stent restenosis: a comprehensive, collaborative, individual patient data meta†…
D Giacoppo, F Alfonso, B Xu, BEPM Claessen, T Adriaenssens, C Jensen, ...
European Heart Journal 41 (38), 3715-3728, 2020
1192020
Impact of intravascular ultrasound imaging on early and late clinical outcomes following percutaneous coronary intervention with drug-eluting stents
BE Claessen, R Mehran, GS Mintz, G Weisz, MB Leon, O Dogan, ...
JACC: Cardiovascular Interventions 4 (9), 974-981, 2011
1172011
The system can't perform the operation now. Try again later.
Articles 1–20